453 related articles for article (PubMed ID: 11931626)
21. NMR-based quality control approach for the identification of false positives and false negatives in high throughput screening.
Dalvit C; Caronni D; Mongelli N; Veronesi M; Vulpetti A
Curr Drug Discov Technol; 2006 Jun; 3(2):115-24. PubMed ID: 16925519
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
23. Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening.
Dessalew N; Bharatam PV
Biophys Chem; 2007 Jul; 128(2-3):165-75. PubMed ID: 17482749
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.
Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA
J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453
[TBL] [Abstract][Full Text] [Related]
25. A detergent-based assay for the detection of promiscuous inhibitors.
Feng BY; Shoichet BK
Nat Protoc; 2006; 1(2):550-3. PubMed ID: 17191086
[TBL] [Abstract][Full Text] [Related]
26. Efficient search of chemical space: navigating from fragments to structurally diverse chemotypes.
Wassermann AM; Kutchukian PS; Lounkine E; Luethi T; Hamon J; Bocker MT; Malik HA; Cowan-Jacob SW; Glick M
J Med Chem; 2013 Nov; 56(21):8879-91. PubMed ID: 24117015
[TBL] [Abstract][Full Text] [Related]
27. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
[TBL] [Abstract][Full Text] [Related]
28. Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures.
Feng BY; Shoichet BK
J Med Chem; 2006 Apr; 49(7):2151-4. PubMed ID: 16570910
[TBL] [Abstract][Full Text] [Related]
29. Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Aslfm).
Škedelj V; Perdih A; Brvar M; Kroflič A; Dubbée V; Savage V; O'Neill AJ; Solmajer T; Bešter-Rogač M; Blanot D; Hugonnet JE; Magnet S; Arthur M; Mainardi JL; Stojan J; Zega A
Eur J Med Chem; 2013 Sep; 67():208-20. PubMed ID: 23867605
[TBL] [Abstract][Full Text] [Related]
30. Development of a receptor model for efficient in silico screening of HIV-1 integrase inhibitors.
Quevedo MA; Ribone SR; Briñón MC; Dehaen W
J Mol Graph Model; 2014 Jul; 52():82-90. PubMed ID: 25023663
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.
Ostrov DA; Hernández Prada JA; Corsino PE; Finton KA; Le N; Rowe TC
Antimicrob Agents Chemother; 2007 Oct; 51(10):3688-98. PubMed ID: 17682095
[TBL] [Abstract][Full Text] [Related]
32. Identification of sumoylation activating enzyme 1 inhibitors by structure-based virtual screening.
Kumar A; Ito A; Hirohama M; Yoshida M; Zhang KY
J Chem Inf Model; 2013 Apr; 53(4):809-20. PubMed ID: 23544417
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel Bruton's tyrosine kinase inhibitors using a hybrid protocol of virtual screening approaches based on SVM model, pharmacophore and molecular docking.
Wan HL; Wang ZR; Li LL; Cheng C; Ji P; Liu JJ; Zhang H; Zou J; Yang SY
Chem Biol Drug Des; 2012 Sep; 80(3):366-73. PubMed ID: 22594639
[TBL] [Abstract][Full Text] [Related]
34. The identification of novel PLC-gamma inhibitors using virtual high throughput screening.
Reynisson J; Court W; O'Neill C; Day J; Patterson L; McDonald E; Workman P; Katan M; Eccles SA
Bioorg Med Chem; 2009 Apr; 17(8):3169-76. PubMed ID: 19303309
[TBL] [Abstract][Full Text] [Related]
35. Is RK-682 a promiscuous enzyme inhibitor? Synthesis and in vitro evaluation of protein tyrosine phosphatase inhibition of racemic RK-682 and analogues.
Carneiro VM; Trivella DB; Scorsato V; Beraldo VL; Dias MP; Sobreira TJ; Aparicio R; Pilli RA
Eur J Med Chem; 2015 Jun; 97():42-54. PubMed ID: 25938987
[TBL] [Abstract][Full Text] [Related]
36. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
37. Discovery of potential pancreatic cholesterol esterase inhibitors using pharmacophore modelling, virtual screening, and optimization studies.
John S; Thangapandian S; Sakkiah S; Lee KW
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):535-45. PubMed ID: 21143043
[TBL] [Abstract][Full Text] [Related]
38. Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation.
Kuck D; Singh N; Lyko F; Medina-Franco JL
Bioorg Med Chem; 2010 Jan; 18(2):822-9. PubMed ID: 20006515
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of tissue-nonspecific alkaline phosphatase (TNAP): from hits to leads.
Teriete P; Pinkerton AB; Cosford ND
Methods Mol Biol; 2013; 1053():85-101. PubMed ID: 23860648
[TBL] [Abstract][Full Text] [Related]
40. Serendipitous discovery of light-induced (In Situ) formation of an Azo-bridged dimeric sulfonated naphthol as a potent PTP1B inhibitor.
Bongard RD; Lepley M; Thakur K; Talipov MR; Nayak J; Lipinski RAJ; Bohl C; Sweeney N; Ramchandran R; Rathore R; Sem DS
BMC Biochem; 2017 May; 18(1):10. PubMed ID: 28569147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
